Toggle navigation
Home
About Us
Pipeline
Collaborations
Investors
Media Center
News Releases
Publications
Events
Careers
Contact Us
Site Map
Home
About Us
Pipeline
Collaborations
Investors
Media Center
News Releases
Publications
Events
Careers
Media Center
News Releases
Publications
Press Releases
Title Filter
Display #
5
10
15
20
25
30
50
100
All
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference
Dec 21, 2018
Lexicon Pharmaceuticals Announces Topline Phase 1 Clinical Results for LX2761 in Diabetes
Dec 20, 2018
Lexicon Pharmaceuticals Announces Positive Topline Clinical Data for LX9211
Dec 18, 2018
FDA Advisory Committee to Review Investigational Sotagliflozin as Potential Treatment for Type 1 Diabetes
Nov 29, 2018
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference
Nov 08, 2018
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference
Nov 06, 2018
Lexicon Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides a Business Update
Nov 01, 2018
Lexicon Pharmaceuticals to Host Third Quarter 2018 Financial Results Conference Call and Webcast on November 1, 2018
Oct 25, 2018
Lexicon Pharmaceuticals and Ipsen Biopharmaceuticals Canada Inc. Announce Health Canada Approval of Xermelo® (telotristat Ethyl) for the Treatment of Refractory Carcinoid Syndrome Diarrhea in Combination with Somatostatin Analog Therapy
Oct 16, 2018
Lexicon Pharmaceuticals to Present Sotagliflozin Clinical Data at the European Association for the Study of Diabetes 54th Annual Meeting
Sep 24, 2018
3
...
5
6
7
8
9
...
11
12
Copyright
©
2020, Lexicon Pharmaceuticals, Inc. All Rights Reserved
Privacy Policy
Terms of Use
Vendor Terms
Contact Us
Sitemap